CVR: 14536604
CAND.PHARM. POVL M. ASSENS FOND is a Danish company of the type Erhvervsdrivende fond based in Glostrup, founded in 1999. The company is registered under the industry Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 13,153,000 compared with DKK 11,790,112 the year before. Equity amounted to DKK 128,614,000.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileFondens formål er: 1. at drive erhvervsvirksomhed, herunder, sålænge bestyrelsen finder det rigtigt, helt eller delvis at eje aktiekapitalen i Biofarma Logistik A/S og om fornødent yde støtte til driften af denne virksomhed 2. at støtte de medicinsk historiske og pharmaceutisk historiske videnskaber og museumsvirksomhed indenfor disse områder 3. i øvrigt at støtte videnskabelige formål
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | - | 13.2 mio. | 131.1 mio. | 128.6 mio. | 56 | |
| 2024 | 0 | 11.8 mio. | 120.1 mio. | 117.5 mio. | 52 | |
| 2023 | 0 | 7.1 mio. | 110 mio. | 107.1 mio. | 53 | |
| 2022 | - | -3.3 mio. | 105 mio. | 101.7 mio. | 47 | |
| 2021 | 0 | 7.3 mio. | 110.3 mio. | 106.1 mio. | 41 | |
| 2020 | 0 | 145 t. | 104 mio. | 101.2 mio. | 37 | |
| 2019 | 0 | 4.9 mio. | 104.3 mio. | 102.9 mio. | 36 | |
| 2018 | 0 | -1.7 mio. | 100.3 mio. | 98.9 mio. | 36 | |
| 2017 | 0 | 5.2 mio. | 103.2 mio. | 101.6 mio. | 32 | |
| 2016 | 0 | 5.1 mio. | 99.3 mio. | 97.2 mio. | 29 | |
| 2015 | 0 | 6.2 mio. | 96 mio. | 89.2 mio. | 31 | |
| 2014 | 0 | 6.9 mio. | 90.2 mio. | 86.3 mio. | - | |
| 2013 | 0 | 3.9 mio. | 84.5 mio. | 82.4 mio. | 28 |
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 574 companies in Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål
Comparison is based on industry median values
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2025. Gross profit came to DKK 0, and the net result was DKK 13,153,000.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK 11,790,112.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK 7,149,344.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2022. The net result was DKK -3,324,757.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK 7,306,072.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK 145,131.
As of August 14, 2020, Tyge Jesper Rothe has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 14, 2020, Søren Wang Petersen has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 14, 2020, Ole Kondrup has left the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 13, 2020, Tyge Jesper Rothe has left the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK 4,924,086.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -1,737,723.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK 5,195,201.
As of November 21, 2017, Ole Kilsgaard has left the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2016. Revenue came to DKK 0, and the net result was DKK 5,087,572.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2015. Revenue came to DKK 0, and the net result was DKK 6,215,620.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2014. Revenue came to DKK 0, and the net result was DKK 6,929,662.
As of February 27, 2015, EY Godkendt Revisionspartnerselskab has been appointed auditor of CAND.PHARM. POVL M. ASSENS FOND.
As of February 27, 2015, JUT NR. 2180 A/S has stepped down as auditor of CAND.PHARM. POVL M. ASSENS FOND.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2013. Revenue came to DKK 0, and the net result was DKK 3,928,348.
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2012.
As of May 26, 2012, JUT NR. 2180 A/S has been appointed auditor of CAND.PHARM. POVL M. ASSENS FOND.
As of May 26, 2012, EY Danmark A/S has stepped down as auditor of CAND.PHARM. POVL M. ASSENS FOND.
As of December 10, 2004, Tyge Jesper Rothe has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of December 10, 2004, Allan Philip has left the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
CAND.PHARM. POVL M. ASSENS FOND was founded on October 16, 1999.
As of September 30, 1992, Povl Michael Assens has left the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 21, 1990, EY Danmark A/S has been appointed auditor of CAND.PHARM. POVL M. ASSENS FOND.
As of August 21, 1990, Allan Philip has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 21, 1990, Povl Michael Assens has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 21, 1990, Ole Kondrup has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 21, 1990, Ole Kilsgaard has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
As of August 21, 1990, Niels Christian Assens has joined the board of directors of CAND.PHARM. POVL M. ASSENS FOND.
Companies in the same industry and area
CVR 11579442
CVR 85842412
CVR 16540714
CVR 11608574
CVR 10480744
companydata.dk